Sulfonamide derivatives as new potent and selective CB2 cannabinoid receptor agonists.
A novel series of sulfonamide derivatives 3, the CB(2) receptor agonists, was synthesized and evaluated for activity against the human CB(2) receptor. We first identified sulfonamide 3a, which was obtained by random screening of our in-house chemical library as a moderately active (CB(2) IC(50)=340nM) CB(2) receptor agonist. We then attempted to test its analogues to identify compounds with a high affinity for the CB(2) receptor. One of these, compound 3f, exhibited high affinity for the human CB(2) receptor (IC(50)=16nM) and high selectivity for CB(2) over CB(1) (CB(1) IC(50)/CB(2)IC(50)=106), and behaved as a full CB(2) receptor agonist in the [(35)S]GTPgammaS binding assay (CB(2) EC(50)=7.2nM, E(max)=100%).
Ohta
Hiroshi
H
Medicinal Chemistry Laboratories, Taisho Pharmaceutical Co., Ltd, 1-403 Yoshino-cho, Kita-ku, Saitama-shi, Saitama 331-9530, Japan. hiroshi.ohta@po.rd.taisho.co.jp
Ishizaka
Tomoko
T
Yoshinaga
Mitsukane
M
Morita
Aki
A
Tomishima
Yasumitsu
Y
Toda
Yoshihisa
Y
Saito
Shuji
S
D006801:Humans; D043885:Receptor, Cannabinoid, CB2 / Q000819:agonists*; D013329:Structure-Activity Relationship; D013449:Sulfonamides / Q000494:pharmacology*
D043885:Receptor, Cannabinoid, CB2; D013449:Sulfonamides